A Combined Bioinformatics and Clinical Validation Study Identifies MDM2, FKBP5 and CTNNA1 as Diagnostic Gene Signatures for COPD in Peripheral Blood Mononuclear Cells
Innokenty A. Savin, Aleksandra V. Sen’kova, Andrey V. Markov, Olga S. Kotova, Ilya S. Shpagin, Lyubov A. Shpagina, Valentin V. Vlassov, Marina A. Zenkova · 2025
Read A Combined Bioinformatics and Clinical Validation Study Identifies MDM2, FKBP5 and CTNNA1 as Diagnostic Gene Signatures for COPD in Peripheral Blood Mononuclear Cells by Innokenty A. Savin, Aleksandra V. Sen’kova, Andrey V. Markov, Olga S. Kotova, Ilya S. Shpagin, Lyubov A. Shpagina, Valentin V. Vlassov, Marina A. Zenkova (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12785598.txt.
Description
Innokenty Savin and co-authors identify blood gene markers in 2025 for chronic lung disease. The disease, called COPD in the paper, is usually found only after lung damage is advanced, so a simple blood test for early stages is needed. The team mines public gene data from blood immune cells of patients.
Network analysis found gene groups tied to the disease, enriched for immune and tissue remodeling paths. Cross-checks narrowed the field to three hub genes, each switched on far more strongly in patients than in healthy volunteers. In a clinic group of twenty-eight patients and thirteen controls, the three genes sorted cases with high accuracy. The authors propose them as a diagnostic signature.
Catalog record
| CREATOR | Innokenty A. Savin, Aleksandra V. Sen’kova, Andrey V. Markov, Olga S. Kotova, Ilya S. Shpagin, Lyubov A. Shpagina, Valentin V. Vlassov, Marina A. Zenkova |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 33 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |